Skip to Content

Benzoyl peroxide / erythromycin topical Pregnancy and Breastfeeding Warnings

Benzoyl peroxide / erythromycin topical is also known as: Aktipak, Benzamycin, Benzamycin Pak

Medically reviewed on Jul 23, 2018

Benzoyl peroxide / erythromycin topical Pregnancy Warnings

Benzoyl peroxide-erythromycin topical has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There was no evidence of teratogenicity when erythromycin was administered orally to rats. There are no controlled data in human pregnancy. Benzoyl peroxide-erythromycin topical should only be used during pregnancy when benefit outweighs risk.

See references

Benzoyl peroxide / erythromycin topical Breastfeeding Warnings

There are no data on the excretion of benzoyl peroxide-erythromycin into human milk. Erythromycin is excreted into milk after systemic administration; however, topical erythromycin undergoes minimal systemic absorption. The American Academy of Pediatrics considers erythromycin compatible with breast-feeding. Benzoyl peroxide undergoes some percutaneous absorption. The manufacturer recommends that caution be used when administering benzoyl peroxide-erythromycin to nursing women.

See references

References for pregnancy information

  1. "Product Information. Benzamycin Topical Gel (benzoyl peroxide-erythromycin topical)" Dermik Laboratories, Collegeville, PA.

References for breastfeeding information

  1. "American Academy of Pediatrics. Committee on Drugs. The transfer of drugs and other chemicals into human milk." Pediatrics 108 (2001): 776-89
  2. "Product Information. Benzamycin Topical Gel (benzoyl peroxide-erythromycin topical)" Dermik Laboratories, Collegeville, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide